Nanomedicine: Nanotechnology, Biology and Medicine
Volume 5, Issue 4 , Pages 410-418 , December 2009

PEGylated PLGA nanoparticles for the improved delivery of doxorubicin

  • Jason Park, MS

      Affiliations

    • Department of Biomedical Engineering, Yale University, New Haven, Connecticut, USA
    • ,
  • Peter M. Fong, PhD

      Affiliations

    • Department of Biomedical Engineering, Yale University, New Haven, Connecticut, USA
    • ,
  • Jing Lu, PhD

      Affiliations

    • Carigent Therapeutics, Inc., New Haven, Connecticut, USA
    • ,
  • Kerry S. Russell, MD, PhD

      Affiliations

    • Department of Internal Medicine, Cardiology, Yale Cardiology, The Anylan Center, New Haven, Connecticut, USA
    • ,
  • Carmen J. Booth, DVM, PhD

      Affiliations

    • Section of Comparative Medicine, Yale Medical School, New Haven, Connecticut, USA
    • ,
  • W. Mark Saltzman, PhD

      Affiliations

    • Department of Biomedical Engineering, Yale University, New Haven, Connecticut, USA
    • Corresponding Author InformationCorresponding author.
    • ,
  • Tarek M. Fahmy, PhD

      Affiliations

    • Department of Biomedical Engineering, Yale University, New Haven, Connecticut, USA

Received 5 November 2008 ,Accepted 13 February 2009.

References 

  1. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001;70:1–20
  2. Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 1997;28:5–24
  3. Okada H, Toguchi H. Biodegradable microspheres in drug-delivery. Crit Rev Ther Drug Carrier Syst. 1995;12:1–99
  4. Goren D, Horowitz AT, Tzemach D, Tarshish M, Zalipsky S, Gabizon A. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Clin Cancer Res. 2000;6:1949–1957
  5. Moghimi SM, Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res. 2003;42:463–478
  6. Faraasen S, Voros J, Csucs G, Textor M, Merkle HP, Walter E. Ligand-specific targeting of microspheres to phagocytes by surface modification with poly(l-lysine)-grafted poly(ethylene glycol) conjugate. Pharm Res. 2003;20:237–246
  7. Gref R, Luck M, Quellec P, Marchand M, Dellacherie E, Harnisch S, et al. ‘Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surfaces B–Biointerfaces. 2000;18:301–313
  8. Li YP, Pei YY, Zhang XY, Gu ZH, Zhou ZH, Yuan WF, et al. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Release. 2001;71:203–211
  9. Yeh ET, Tong AT, Lenihan DJ, Yusuf SW, Swafford J, Champion C, et al. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation. 2004;109:3122–3131
  10. Allen TM, Martin FJ. Advantages of liposomal delivery systems for anthracyclines. Semin Oncol. 2004;31:5–15
  11. Biragyn A, Kwak LW. Models for lymphoma. In: Coico R editors. Current protocols in immunology. Hoboken, NJ: John Wiley and Sons, Inc.; 2001;p. 20.6.1–20.6.30
  12. Fahmy TM, Samstein RM, Harness CC, Saltzman WM. Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting. Biomaterials. 2005;26:5727–5736
  13. Myers CE, McGuire WP, Liss RH, Ifrim I, Grotzinger K, Young RC. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science. 1977;197:165–167
  14. Kang YJ, Chen Y, Epstein PN. Suppression of cardiotoxicity by overexpression of catalase in the heart of transgenic mice. J Biol Chem. 1996;271:12610–12616
  15. Teraoka K, Hirano M, Yamaguchi K, Yamashina A. Progressive cardiac dysfunction in adriamycin-induced cardiomyopathy rats. Eur J Heart Fail. 2000;2:373–378
  16. Jacoby JJ, Kalinowski A, Liu MG, Zhang SSM, Gao Q, Chai GX, et al. Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age. Proc Natl Acad Sci U S A. 2003;100:12929–12934
  17. Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 2008;7:771–782
  18. Johansen PB. Doxorubicin pharmacokinetics after intravenous and intraperitoneal administration in the nude-mouse. Cancer Chemother Pharmacol. 1981;5:267–270
  19. Bouma J, Beijnen JH, Bult A, Underberg WJM. Anthracycline antitumour agents. Pharm World Sci. 1986;8:109–133
  20. Allen TM, Mumbengegwi DR, Charrois GJR. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates. Clin Cancer Res. 2005;11:3567–3573
  21. Shen H, Ackerman AL, Cody V, Giodini A, Hinson ER, Cresswell P, et al. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Immunology. 2006;117:78–88
  22. Lamprecht A, Benoit JP. Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glyco-protein inhibition. J Control Release. 2006;112:208–213
  23. Soma CE, Dubernet C, Barratt G, Nemati F, Appol M, Benita S, et al. Ability of doxorubicin-loaded nanoparticles to overcome multidrug resistance of tumor cells after their capture by macrophages. Pharm Res. 1999;16:1710–1716
  24. Wong HL, Bendayan R, Rauth AM, Wu XY. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new Polymer-Lipid Hybrid Nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer. J Control Release. 2006;116:275–284

 This work was supported by a grant to W.M.S. from the National Institutes of Health (EB000487) and a career award to T.M.F. from the Wallace Coulter Foundation.

PII: S1549-9634(09)00056-2

doi: 10.1016/j.nano.2009.02.002

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 5, Issue 4 , Pages 410-418 , December 2009

Article Tools

* Image Usage & Resolution